Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001919944 | SCV002162906 | uncertain significance | Congenital glucose-galactose malabsorption | 2022-10-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1396323). This variant has not been reported in the literature in individuals affected with SLC5A1-related conditions. This variant is present in population databases (rs767673239, gnomAD 0.002%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 52 of the SLC5A1 protein (p.Arg52Cys). |
Fulgent Genetics, |
RCV001919944 | SCV002775235 | uncertain significance | Congenital glucose-galactose malabsorption | 2021-07-09 | criteria provided, single submitter | clinical testing |